Entry |
|
Name |
Loteprednol (INN) |
Formula |
C21H27ClO5
|
Exact mass |
394.1547
|
Mol weight |
394.8891
|
Structure |
|
Simcomp |
|
Class |
|
Remark |
Product (DG01127): | D01689<US> |
|
Efficacy |
Anti-inflammatory (ophthalmic), Glucocorticoid receptor agonist |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01B ANTIINFLAMMATORY AGENTS
S01BA Corticosteroids, plain
S01BA14 Loteprednol
D08147 Loteprednol (INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG01127 Loteprednol
D08147 Loteprednol
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D08147 Loteprednol (INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG01127 Loteprednol
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 27
1 C1z C 25.6200 -17.0800
2 C1z C 24.5000 -17.7800
3 C1x C 26.8100 -17.7800
4 C7a C 25.6900 -15.7500
5 O1a O 26.8800 -16.3800
6 C1y C 24.5000 -19.1800
7 C1x C 23.3100 -17.0800
8 C1a C 24.4300 -16.3800
9 C1x C 26.8100 -19.1800
10 O7a O 24.5000 -14.9800
11 O6a O 26.8800 -15.0500
12 C1y C 23.2400 -19.8100
13 C1y C 22.0500 -17.7100
14 C1b C 23.3100 -15.6800
15 C1y C 22.0500 -19.1100
16 C1x C 23.2400 -21.1400
17 O1a O 20.9300 -17.0800
18 X Cl 22.0500 -14.9800
19 C1z C 20.8600 -19.8100
20 C1x C 22.0500 -21.8400
21 C2y C 20.8600 -21.1400
22 C2x C 19.7400 -19.1100
23 C1a C 20.8600 -18.4100
24 C2x C 19.7400 -21.8400
25 C2x C 18.5500 -19.8100
26 C5x C 18.5500 -21.1400
27 O5x O 17.3600 -21.8400
BOND 30
1 1 5 1 #Down
2 2 6 1
3 2 7 1
4 2 8 1 #Up
5 3 9 1
6 4 10 1
7 4 11 2
8 6 12 1
9 7 13 1
10 10 14 1
11 12 15 1
12 12 16 1
13 13 17 1 #Up
14 14 18 1
15 15 19 1
16 16 20 1
17 19 21 1
18 19 22 1
19 19 23 1 #Up
20 21 24 2
21 22 25 2
22 24 26 1
23 26 27 2
24 6 9 1
25 13 15 1
26 20 21 1
27 25 26 1
28 1 2 1
29 1 3 1
30 1 4 1 #Up
|